Wilmington, Del.-based Nemours Children’s Health received more than $10 million in National Institutes of Health funding during the third quarter of 2026 to support research addressing pediatric health conditions.
The awards mark the largest single wave of NIH funding Nemours has received over one calendar quarter in its 90-year history, Matthew Davis, MD, executive vice president, enterprise physician-in-chief and chief scientific officer, said Nov. 12. Dr. Davis said the funding signals “the increasing breadth and momentum of Nemours research.”
The grants will support research across several specialties, including Type 1 diabetes, sickle cell disease, childhood obesity, neonatal care and pediatric cardiac arrest.
Among the funded projects, researchers will evaluate a peer mentorship program to help children with Type 1 diabetes use continuous glucose monitors across three children’s hospitals. Another team will test an AI tool integrated into the EHR to help primary care providers understand a child’s future growth patterns and support obesity prevention.
Other projects will investigate artificial placenta technology for premature infants, genetic factors behind hypospadias and undescended testes and a gene tied to colitis. Researchers will also study myocardial dysfunction and later neurological function among 200 children who survived cardiac arrest.
